Industry Research Reports

Part 1

Part 2

Part 3

Part 4

Part 5

Home > Reports > Medical Care > Global Subcutaneous Injection Market Insights, Forecast to 2030

Global Subcutaneous Injection Market Insights, Forecast to 2030

Industry: Medical Care

Published: 2024-04-26

Pages: 105 Pages

Report ld: 3080247

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description

A subcutaneous injection is administered as a bolus into the subcutis, the layer of skin directly below the dermis and epidermis, collectively referred to as the cutis. Subcutaneous injections are highly effective in administering vaccines and medications such as insulin, morphine, diacetylmorphine and goserelin. Subcutaneous, as opposed to intravenous, injection of recreational drugs is referred to as "skin popping". Subcutaneous administration may be abbreviated as SC, SQ, sub-cu, sub-Q, SubQ, or subcut. Subcut is the preferred abbreviation for patient safety.

Market Analysis and Insights: Global Subcutaneous Injection Market

The global Subcutaneous Injection market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Subcutaneous Injection is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Subcutaneous Injection is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Subcutaneous Injection is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key companies of Subcutaneous Injection include Becton Dickinson, Daiichi Sankyo, Sanofi, Roche, GSK, Eli Lilly, Asahi Kasei Pharma, Takeda Pharmaceutical and Antares Pharma, Inc., etc. In 2023, the global top five players had a share approximately % in terms of revenue.

Subcutaneous Injection is widely used in various fields, such as Hospital, Clinic, Laboratory and Others, etc. Hospital provides greatest supports to the Subcutaneous Injection industry development. In 2023, global % revenue of Subcutaneous Injection went into Hospital filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Subcutaneous Injection market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Subcutaneous Injection, also provides the revenue of main regions and countries. of the upcoming market potential for Subcutaneous Injection, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Subcutaneous Injection revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Subcutaneous Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Subcutaneous Injection revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Becton Dickinson, Daiichi Sankyo, Sanofi, Roche, GSK, Eli Lilly, Asahi Kasei Pharma, Takeda Pharmaceutical and Antares Pharma, Inc., etc.

Market Segmentation

Report Metric
Details
Report Title
Global Subcutaneous Injection Market Insights, Forecast to 2030
Market Size Available for Years
2024-2030
Global Subcutaneous Injection Companies Covered
Becton Dickinson
Daiichi Sankyo
Sanofi
Roche
GSK
Eli Lilly
Asahi Kasei Pharma
Takeda Pharmaceutical
Antares Pharma, Inc.
Eisai Co.，Ltd
Chugai Pharmaceutical
Endo International
PenJet Corporation
Aspen Medical Group
Global Subcutaneous Injection Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Subcutaneous Injection Market, Segment by Type
Subcutaneous Injection Equipment
Subcutaneous Injection Drug
Others
Global Subcutaneous Injection Market, Segment by Application
Hospital
Clinic
Laboratory
Others
Forecast Units
Million USD
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Subcutaneous Injection in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Subcutaneous Injection companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Subcutaneous Injection revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

Table of Contents

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Subcutaneous Injection Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
        1.2.2 Subcutaneous Injection Equipment
        1.2.3 Subcutaneous Injection Drug
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Subcutaneous Injection Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Laboratory
        1.3.5 Others
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

2 Global Growth Trends
    2.1 Global Subcutaneous Injection Market Perspective (2019-2030)
    2.2 Global Subcutaneous Injection Growth Trends by Region
        2.2.1 Subcutaneous Injection Market Size by Region: 2019 VS 2023 VS 2030
        2.2.2 Subcutaneous Injection Historic Market Size by Region (2019-2024)
        2.2.3 Subcutaneous Injection Forecasted Market Size by Region (2025-2030)
    2.3 Subcutaneous Injection Market Dynamics
        2.3.1 Subcutaneous Injection Industry Trends
        2.3.2 Subcutaneous Injection Market Drivers
        2.3.3 Subcutaneous Injection Market Challenges
        2.3.4 Subcutaneous Injection Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Revenue Subcutaneous Injection by Players
        3.1.1 Global Subcutaneous Injection Revenue by Players (2019-2024)
        3.1.2 Global Subcutaneous Injection Revenue Market Share by Players (2019-2024)
    3.2 Global Subcutaneous Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Global Key Players of Subcutaneous Injection, Ranking by Revenue, 2022 VS 2023 VS 2024
    3.4 Global Subcutaneous Injection Market Concentration Ratio
        3.4.1 Global Subcutaneous Injection Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Subcutaneous Injection Revenue in 2023
    3.5 Global Key Players of Subcutaneous Injection Head office and Area Served
    3.6 Global Key Players of Subcutaneous Injection, Product and Application
    3.7 Global Key Players of Subcutaneous Injection, Date of Enter into This Industry
    3.8 Mergers & Acquisitions, Expansion Plans

4 Subcutaneous Injection Breakdown Data by Type
    4.1 Global Subcutaneous Injection Historic Market Size by Type (2019-2024)
    4.2 Global Subcutaneous Injection Forecasted Market Size by Type (2025-2030)

5 Subcutaneous Injection Breakdown Data by Application
    5.1 Global Subcutaneous Injection Historic Market Size by Application (2019-2024)
    5.2 Global Subcutaneous Injection Forecasted Market Size by Application (2025-2030)

6 North America
    6.1 North America Subcutaneous Injection Market Size (2019-2030)
    6.2 North America Subcutaneous Injection Market Size by Type
        6.2.1 North America Subcutaneous Injection Market Size by Type (2019-2024)
        6.2.2 North America Subcutaneous Injection Market Size by Type (2025-2030)
        6.2.3 North America Subcutaneous Injection Market Share by Type (2019-2030)
    6.3 North America Subcutaneous Injection Market Size by Application
        6.3.1 North America Subcutaneous Injection Market Size by Application (2019-2024)
        6.3.2 North America Subcutaneous Injection Market Size by Application (2025-2030)
        6.3.3 North America Subcutaneous Injection Market Share by Application (2019-2030)
    6.4 North America Subcutaneous Injection Market Size by Country
        6.4.1 North America Subcutaneous Injection Market Size by Country: 2019 VS 2023 VS 2030
        6.4.2 North America Subcutaneous Injection Market Size by Country (2019-2024)
        6.4.3 North America Subcutaneous Injection Market Size by Country (2025-2030)
        6.4.4 U.S.
        6.4.5 Canada

7 Europe
    7.1 Europe Subcutaneous Injection Market Size (2019-2030)
    7.2 Europe Subcutaneous Injection Market Size by Type
        7.2.1 Europe Subcutaneous Injection Market Size by Type (2019-2024)
        7.2.2 Europe Subcutaneous Injection Market Size by Type (2025-2030)
        7.2.3 Europe Subcutaneous Injection Market Share by Type (2019-2030)
    7.3 Europe Subcutaneous Injection Market Size by Application
        7.3.1 Europe Subcutaneous Injection Market Size by Application (2019-2024)
        7.3.2 Europe Subcutaneous Injection Market Size by Application (2025-2030)
        7.3.3 Europe Subcutaneous Injection Market Share by Application (2019-2030)
    7.4 Europe Subcutaneous Injection Market Size by Country
        7.4.1 Europe Subcutaneous Injection Market Size by Country: 2019 VS 2023 VS 2030
        7.4.2 Europe Subcutaneous Injection Market Size by Country (2019-2024)
        7.4.3 Europe Subcutaneous Injection Market Size by Country (2025-2030)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries

8 China
    8.1 China Subcutaneous Injection Market Size (2019-2030)
    8.2 China Subcutaneous Injection Market Size by Type
        8.2.1 China Subcutaneous Injection Market Size by Type (2019-2024)
        8.2.2 China Subcutaneous Injection Market Size by Type (2025-2030)
        8.2.3 China Subcutaneous Injection Market Share by Type (2019-2030)
    8.3 China Subcutaneous Injection Market Size by Application
        8.3.1 China Subcutaneous Injection Market Size by Application (2019-2024)
        8.3.2 China Subcutaneous Injection Market Size by Application (2025-2030)
        8.3.3 China Subcutaneous Injection Market Share by Application (2019-2030)

9 Asia (excluding China)
    9.1 Asia Subcutaneous Injection Market Size (2019-2030)
    9.2 Asia Subcutaneous Injection Market Size by Type
        9.2.1 Asia Subcutaneous Injection Market Size by Type (2019-2024)
        9.2.2 Asia Subcutaneous Injection Market Size by Type (2025-2030)
        9.2.3 Asia Subcutaneous Injection Market Share by Type (2019-2030)
    9.3 Asia Subcutaneous Injection Market Size by Application
        9.3.1 Asia Subcutaneous Injection Market Size by Application (2019-2024)
        9.3.2 Asia Subcutaneous Injection Market Size by Application (2025-2030)
        9.3.3 Asia Subcutaneous Injection Market Share by Application (2019-2030)
    9.4 Asia Subcutaneous Injection Market Size by Region
        9.4.1 Asia Subcutaneous Injection Market Size by Region: 2019 VS 2023 VS 2030
        9.4.2 Asia Subcutaneous Injection Market Size by Region (2019-2024)
        9.4.3 Asia Subcutaneous Injection Market Size by Region (2025-2030)
        9.4.4 Japan
        9.4.5 South Korea
        9.4.6 China Taiwan
        9.4.7 Southeast Asia
        9.4.8 India
        9.4.9 Australia

10 Middle East, Africa, and Latin America
    10.1 Middle East, Africa, and Latin America Subcutaneous Injection Market Size (2019-2030)
    10.2 Middle East, Africa, and Latin America Subcutaneous Injection Market Size by Type
        10.2.1 Middle East, Africa, and Latin America Subcutaneous Injection Market Size by Type (2019-2024)
        10.2.2 Middle East, Africa, and Latin America Subcutaneous Injection Market Size by Type (2025-2030)
        10.2.3 Middle East, Africa, and Latin America Subcutaneous Injection Market Share by Type (2019-2030)
    10.3 Middle East, Africa, and Latin America Subcutaneous Injection Market Size by Application
        10.3.1 Middle East, Africa, and Latin America Subcutaneous Injection Market Size by Application (2019-2024)
        10.3.2 Middle East, Africa, and Latin America Subcutaneous Injection Market Size by Application (2025-2030)
        10.3.3 Middle East, Africa, and Latin America Subcutaneous Injection Market Share by Application (2019-2030)
    10.4 Middle East, Africa, and Latin America Subcutaneous Injection Market Size by Country
        10.4.1 Middle East, Africa, and Latin America Subcutaneous Injection Market Size by Country: 2019 VS 2023 VS 2030
        10.4.2 Middle East, Africa, and Latin America Subcutaneous Injection Market Size by Country (2019-2024)
        10.4.3 Middle East, Africa, and Latin America Subcutaneous Injection Market Size by Country (2025-2030)
        10.4.4 Brazil
        10.4.5 Mexico
        10.4.6 Turkey
        10.4.7 Saudi Arabia
        10.4.8 Israel
        10.4.9 GCC Countries

11 Key Players Profiles
    11.1 Becton Dickinson
        11.1.1 Becton Dickinson Company Details
        11.1.2 Becton Dickinson Business Overview
        11.1.3 Becton Dickinson Subcutaneous Injection Introduction
        11.1.4 Becton Dickinson Revenue in Subcutaneous Injection Business (2019-2024)
        11.1.5 Becton Dickinson Recent Developments
    11.2 Daiichi Sankyo
        11.2.1 Daiichi Sankyo Company Details
        11.2.2 Daiichi Sankyo Business Overview
        11.2.3 Daiichi Sankyo Subcutaneous Injection Introduction
        11.2.4 Daiichi Sankyo Revenue in Subcutaneous Injection Business (2019-2024)
        11.2.5 Daiichi Sankyo Recent Developments
    11.3 Sanofi
        11.3.1 Sanofi Company Details
        11.3.2 Sanofi Business Overview
        11.3.3 Sanofi Subcutaneous Injection Introduction
        11.3.4 Sanofi Revenue in Subcutaneous Injection Business (2019-2024)
        11.3.5 Sanofi Recent Developments
    11.4 Roche
        11.4.1 Roche Company Details
        11.4.2 Roche Business Overview
        11.4.3 Roche Subcutaneous Injection Introduction
        11.4.4 Roche Revenue in Subcutaneous Injection Business (2019-2024)
        11.4.5 Roche Recent Developments
    11.5 GSK
        11.5.1 GSK Company Details
        11.5.2 GSK Business Overview
        11.5.3 GSK Subcutaneous Injection Introduction
        11.5.4 GSK Revenue in Subcutaneous Injection Business (2019-2024)
        11.5.5 GSK Recent Developments
    11.6 Eli Lilly
        11.6.1 Eli Lilly Company Details
        11.6.2 Eli Lilly Business Overview
        11.6.3 Eli Lilly Subcutaneous Injection Introduction
        11.6.4 Eli Lilly Revenue in Subcutaneous Injection Business (2019-2024)
        11.6.5 Eli Lilly Recent Developments
    11.7 Asahi Kasei Pharma
        11.7.1 Asahi Kasei Pharma Company Details
        11.7.2 Asahi Kasei Pharma Business Overview
        11.7.3 Asahi Kasei Pharma Subcutaneous Injection Introduction
        11.7.4 Asahi Kasei Pharma Revenue in Subcutaneous Injection Business (2019-2024)
        11.7.5 Asahi Kasei Pharma Recent Developments
    11.8 Takeda Pharmaceutical
        11.8.1 Takeda Pharmaceutical Company Details
        11.8.2 Takeda Pharmaceutical Business Overview
        11.8.3 Takeda Pharmaceutical Subcutaneous Injection Introduction
        11.8.4 Takeda Pharmaceutical Revenue in Subcutaneous Injection Business (2019-2024)
        11.8.5 Takeda Pharmaceutical Recent Developments
    11.9 Antares Pharma, Inc.
        11.9.1 Antares Pharma, Inc. Company Details
        11.9.2 Antares Pharma, Inc. Business Overview
        11.9.3 Antares Pharma, Inc. Subcutaneous Injection Introduction
        11.9.4 Antares Pharma, Inc. Revenue in Subcutaneous Injection Business (2019-2024)
        11.9.5 Antares Pharma, Inc. Recent Developments
    11.10 Eisai Co.，Ltd
        11.10.1 Eisai Co.，Ltd Company Details
        11.10.2 Eisai Co.，Ltd Business Overview
        11.10.3 Eisai Co.，Ltd Subcutaneous Injection Introduction
        11.10.4 Eisai Co.，Ltd Revenue in Subcutaneous Injection Business (2019-2024)
        11.10.5 Eisai Co.，Ltd Recent Developments
    11.11 Chugai Pharmaceutical
        11.11.1 Chugai Pharmaceutical Company Details
        11.11.2 Chugai Pharmaceutical Business Overview
        11.11.3 Chugai Pharmaceutical Subcutaneous Injection Introduction
        11.11.4 Chugai Pharmaceutical Revenue in Subcutaneous Injection Business (2019-2024)
        11.11.5 Chugai Pharmaceutical Recent Developments
    11.12 Endo International
        11.12.1 Endo International Company Details
        11.12.2 Endo International Business Overview
        11.12.3 Endo International Subcutaneous Injection Introduction
        11.12.4 Endo International Revenue in Subcutaneous Injection Business (2019-2024)
        11.12.5 Endo International Recent Developments
    11.13 PenJet Corporation
        11.13.1 PenJet Corporation Company Details
        11.13.2 PenJet Corporation Business Overview
        11.13.3 PenJet Corporation Subcutaneous Injection Introduction
        11.13.4 PenJet Corporation Revenue in Subcutaneous Injection Business (2019-2024)
        11.13.5 PenJet Corporation Recent Developments
    11.14 Aspen Medical Group
        11.14.1 Aspen Medical Group Company Details
        11.14.2 Aspen Medical Group Business Overview
        11.14.3 Aspen Medical Group Subcutaneous Injection Introduction
        11.14.4 Aspen Medical Group Revenue in Subcutaneous Injection Business (2019-2024)
        11.14.5 Aspen Medical Group Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

Table of Figures

List of Tables
    Table 1. Global Subcutaneous Injection Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Subcutaneous Injection Equipment
    Table 3. Key Players of Subcutaneous Injection Drug
    Table 4. Key Players of Others
    Table 5. Global Subcutaneous Injection Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 6. Global Subcutaneous Injection Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Subcutaneous Injection Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Subcutaneous Injection Market Share by Region (2019-2024)
    Table 9. Global Subcutaneous Injection Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Subcutaneous Injection Market Share by Region (2025-2030)
    Table 11. Subcutaneous Injection Market Trends
    Table 12. Subcutaneous Injection Market Drivers
    Table 13. Subcutaneous Injection Market Challenges
    Table 14. Subcutaneous Injection Market Restraints
    Table 15. Global Subcutaneous Injection Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Subcutaneous Injection Revenue Share by Players (2019-2024)
    Table 17. Global Top Subcutaneous Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Subcutaneous Injection as of 2023)
    Table 18. Global Subcutaneous Injection Industry Ranking 2022 VS 2023 VS 2024
    Table 19. Global 5 Largest Players Market Share by Subcutaneous Injection Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Global Key Players of Subcutaneous Injection, Headquarters and Area Served
    Table 21. Global Key Players of Subcutaneous Injection, Product and Application
    Table 22. Global Key Players of Subcutaneous Injection, Product and Application
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Subcutaneous Injection Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Subcutaneous Injection Revenue Market Share by Type (2019-2024)
    Table 26. Global Subcutaneous Injection Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Subcutaneous Injection Revenue Market Share by Type (2025-2030)
    Table 28. Global Subcutaneous Injection Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Subcutaneous Injection Revenue Share by Application (2019-2024)
    Table 30. Global Subcutaneous Injection Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Subcutaneous Injection Revenue Share by Application (2025-2030)
    Table 32. North America Subcutaneous Injection Market Size by Type (2019-2024) & (US$ Million)
    Table 33. North America Subcutaneous Injection Market Size by Type (2025-2030) & (US$ Million)
    Table 34. North America Subcutaneous Injection Market Size by Application (2019-2024) & (US$ Million)
    Table 35. North America Subcutaneous Injection Market Size by Application (2025-2030) & (US$ Million)
    Table 36. North America Subcutaneous Injection Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. North America Subcutaneous Injection Market Size by Country (2019-2024) & (US$ Million)
    Table 38. North America Subcutaneous Injection Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Europe Subcutaneous Injection Market Size by Type (2019-2024) & (US$ Million)
    Table 40. Europe Subcutaneous Injection Market Size by Type (2025-2030) & (US$ Million)
    Table 41. Europe Subcutaneous Injection Market Size by Application (2019-2024) & (US$ Million)
    Table 42. Europe Subcutaneous Injection Market Size by Application (2025-2030) & (US$ Million)
    Table 43. Europe Subcutaneous Injection Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Europe Subcutaneous Injection Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Europe Subcutaneous Injection Market Size by Country (2025-2030) & (US$ Million)
    Table 46. China Subcutaneous Injection Market Size by Type (2019-2024) & (US$ Million)
    Table 47. China Subcutaneous Injection Market Size by Type (2025-2030) & (US$ Million)
    Table 48. China Subcutaneous Injection Market Size by Application (2019-2024) & (US$ Million)
    Table 49. China Subcutaneous Injection Market Size by Application (2025-2030) & (US$ Million)
    Table 50. Asia Subcutaneous Injection Market Size by Type (2019-2024) & (US$ Million)
    Table 51. Asia Subcutaneous Injection Market Size by Type (2025-2030) & (US$ Million)
    Table 52. Asia Subcutaneous Injection Market Size by Application (2019-2024) & (US$ Million)
    Table 53. Asia Subcutaneous Injection Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia Subcutaneous Injection Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 55. Asia Subcutaneous Injection Market Size by Region (2019-2024) & (US$ Million)
    Table 56. Asia Subcutaneous Injection Market Size by Region (2025-2030) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Subcutaneous Injection Market Size by Type (2019-2024) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Subcutaneous Injection Market Size by Type (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Subcutaneous Injection Market Size by Application (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Subcutaneous Injection Market Size by Application (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Subcutaneous Injection Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 62. Middle East, Africa, and Latin America Subcutaneous Injection Market Size by Country (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Subcutaneous Injection Market Size by Country (2025-2030) & (US$ Million)
    Table 64. Becton Dickinson Company Details
    Table 65. Becton Dickinson Business Overview
    Table 66. Becton Dickinson Subcutaneous Injection Product
    Table 67. Becton Dickinson Revenue in Subcutaneous Injection Business (2019-2024) & (US$ Million)
    Table 68. Becton Dickinson Recent Developments
    Table 69. Daiichi Sankyo Company Details
    Table 70. Daiichi Sankyo Business Overview
    Table 71. Daiichi Sankyo Subcutaneous Injection Product
    Table 72. Daiichi Sankyo Revenue in Subcutaneous Injection Business (2019-2024) & (US$ Million)
    Table 73. Daiichi Sankyo Recent Developments
    Table 74. Sanofi Company Details
    Table 75. Sanofi Business Overview
    Table 76. Sanofi Subcutaneous Injection Product
    Table 77. Sanofi Revenue in Subcutaneous Injection Business (2019-2024) & (US$ Million)
    Table 78. Sanofi Recent Developments
    Table 79. Roche Company Details
    Table 80. Roche Business Overview
    Table 81. Roche Subcutaneous Injection Product
    Table 82. Roche Revenue in Subcutaneous Injection Business (2019-2024) & (US$ Million)
    Table 83. Roche Recent Developments
    Table 84. GSK Company Details
    Table 85. GSK Business Overview
    Table 86. GSK Subcutaneous Injection Product
    Table 87. GSK Revenue in Subcutaneous Injection Business (2019-2024) & (US$ Million)
    Table 88. GSK Recent Developments
    Table 89. Eli Lilly Company Details
    Table 90. Eli Lilly Business Overview
    Table 91. Eli Lilly Subcutaneous Injection Product
    Table 92. Eli Lilly Revenue in Subcutaneous Injection Business (2019-2024) & (US$ Million)
    Table 93. Eli Lilly Recent Developments
    Table 94. Asahi Kasei Pharma Company Details
    Table 95. Asahi Kasei Pharma Business Overview
    Table 96. Asahi Kasei Pharma Subcutaneous Injection Product
    Table 97. Asahi Kasei Pharma Revenue in Subcutaneous Injection Business (2019-2024) & (US$ Million)
    Table 98. Asahi Kasei Pharma Recent Developments
    Table 99. Takeda Pharmaceutical Company Details
    Table 100. Takeda Pharmaceutical Business Overview
    Table 101. Takeda Pharmaceutical Subcutaneous Injection Product
    Table 102. Takeda Pharmaceutical Revenue in Subcutaneous Injection Business (2019-2024) & (US$ Million)
    Table 103. Takeda Pharmaceutical Recent Developments
    Table 104. Antares Pharma, Inc. Company Details
    Table 105. Antares Pharma, Inc. Business Overview
    Table 106. Antares Pharma, Inc. Subcutaneous Injection Product
    Table 107. Antares Pharma, Inc. Revenue in Subcutaneous Injection Business (2019-2024) & (US$ Million)
    Table 108. Antares Pharma, Inc. Recent Developments
    Table 109. Eisai Co.，Ltd Company Details
    Table 110. Eisai Co.，Ltd Business Overview
    Table 111. Eisai Co.，Ltd Subcutaneous Injection Product
    Table 112. Eisai Co.，Ltd Revenue in Subcutaneous Injection Business (2019-2024) & (US$ Million)
    Table 113. Eisai Co.，Ltd Recent Developments
    Table 114. Chugai Pharmaceutical Company Details
    Table 115. Chugai Pharmaceutical Business Overview
    Table 116. Chugai Pharmaceutical Subcutaneous Injection Product
    Table 117. Chugai Pharmaceutical Revenue in Subcutaneous Injection Business (2019-2024) & (US$ Million)
    Table 118. Chugai Pharmaceutical Recent Developments
    Table 119. Endo International Company Details
    Table 120. Endo International Business Overview
    Table 121. Endo International Subcutaneous Injection Product
    Table 122. Endo International Revenue in Subcutaneous Injection Business (2019-2024) & (US$ Million)
    Table 123. Endo International Recent Developments
    Table 124. PenJet Corporation Company Details
    Table 125. PenJet Corporation Business Overview
    Table 126. PenJet Corporation Subcutaneous Injection Product
    Table 127. PenJet Corporation Revenue in Subcutaneous Injection Business (2019-2024) & (US$ Million)
    Table 128. PenJet Corporation Recent Developments
    Table 129. Aspen Medical Group Company Details
    Table 130. Aspen Medical Group Business Overview
    Table 131. Aspen Medical Group Subcutaneous Injection Product
    Table 132. Aspen Medical Group Revenue in Subcutaneous Injection Business (2019-2024) & (US$ Million)
    Table 133. Aspen Medical Group Recent Developments
    Table 134. Research Programs/Design for This Report
    Table 135. Key Data Information from Secondary Sources
    Table 136. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Subcutaneous Injection Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Subcutaneous Injection Market Share by Type: 2023 VS 2030
    Figure 3. Subcutaneous Injection Equipment Features
    Figure 4. Subcutaneous Injection Drug Features
    Figure 5. Others Features
    Figure 6. Global Subcutaneous Injection Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Subcutaneous Injection Market Share by Application: 2023 VS 2030
    Figure 8. Hospital Case Studies
    Figure 9. Clinic Case Studies
    Figure 10. Laboratory Case Studies
    Figure 11. Others Case Studies
    Figure 12. Subcutaneous Injection Report Years Considered
    Figure 13. Global Subcutaneous Injection Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global Subcutaneous Injection Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Subcutaneous Injection Market Share by Region: 2023 VS 2030
    Figure 16. Global Subcutaneous Injection Market Share by Players in 2023
    Figure 17. Global Top Subcutaneous Injection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Subcutaneous Injection as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by Subcutaneous Injection Revenue in 2023
    Figure 19. North America Subcutaneous Injection Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America Subcutaneous Injection Market Share by Type (2019-2030)
    Figure 21. North America Subcutaneous Injection Market Share by Application (2019-2030)
    Figure 22. North America Subcutaneous Injection Market Share by Country (2019-2030)
    Figure 23. United States Subcutaneous Injection Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Canada Subcutaneous Injection Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Subcutaneous Injection Market Size YoY (2019-2030) & (US$ Million)
    Figure 26. Europe Subcutaneous Injection Market Share by Type (2019-2030)
    Figure 27. Europe Subcutaneous Injection Market Share by Application (2019-2030)
    Figure 28. Europe Subcutaneous Injection Market Share by Country (2019-2030)
    Figure 29. Germany Subcutaneous Injection Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. France Subcutaneous Injection Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. U.K. Subcutaneous Injection Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Italy Subcutaneous Injection Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Russia Subcutaneous Injection Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Nordic Countries Subcutaneous Injection Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. China Subcutaneous Injection Market Size YoY (2019-2030) & (US$ Million)
    Figure 36. China Subcutaneous Injection Market Share by Type (2019-2030)
    Figure 37. China Subcutaneous Injection Market Share by Application (2019-2030)
    Figure 38. Asia Subcutaneous Injection Market Size YoY (2019-2030) & (US$ Million)
    Figure 39. Asia Subcutaneous Injection Market Share by Type (2019-2030)
    Figure 40. Asia Subcutaneous Injection Market Share by Application (2019-2030)
    Figure 41. Asia Subcutaneous Injection Market Share by Region (2019-2030)
    Figure 42. Japan Subcutaneous Injection Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. South Korea Subcutaneous Injection Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. China Taiwan Subcutaneous Injection Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Subcutaneous Injection Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. India Subcutaneous Injection Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Australia Subcutaneous Injection Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Subcutaneous Injection Market Size YoY (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Subcutaneous Injection Market Share by Type (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Subcutaneous Injection Market Share by Application (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Subcutaneous Injection Market Share by Country (2019-2030)
    Figure 52. Brazil Subcutaneous Injection Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Mexico Subcutaneous Injection Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Turkey Subcutaneous Injection Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Saudi Arabia Subcutaneous Injection Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Israel Subcutaneous Injection Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. GCC Countries Subcutaneous Injection Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Becton Dickinson Revenue Growth Rate in Subcutaneous Injection Business (2019-2024)
    Figure 59. Daiichi Sankyo Revenue Growth Rate in Subcutaneous Injection Business (2019-2024)
    Figure 60. Sanofi Revenue Growth Rate in Subcutaneous Injection Business (2019-2024)
    Figure 61. Roche Revenue Growth Rate in Subcutaneous Injection Business (2019-2024)
    Figure 62. GSK Revenue Growth Rate in Subcutaneous Injection Business (2019-2024)
    Figure 63. Eli Lilly Revenue Growth Rate in Subcutaneous Injection Business (2019-2024)
    Figure 64. Asahi Kasei Pharma Revenue Growth Rate in Subcutaneous Injection Business (2019-2024)
    Figure 65. Takeda Pharmaceutical Revenue Growth Rate in Subcutaneous Injection Business (2019-2024)
    Figure 66. Antares Pharma, Inc. Revenue Growth Rate in Subcutaneous Injection Business (2019-2024)
    Figure 67. Eisai Co.，Ltd Revenue Growth Rate in Subcutaneous Injection Business (2019-2024)
    Figure 68. Chugai Pharmaceutical Revenue Growth Rate in Subcutaneous Injection Business (2019-2024)
    Figure 69. Endo International Revenue Growth Rate in Subcutaneous Injection Business (2019-2024)
    Figure 70. PenJet Corporation Revenue Growth Rate in Subcutaneous Injection Business (2019-2024)
    Figure 71. Aspen Medical Group Revenue Growth Rate in Subcutaneous Injection Business (2019-2024)
    Figure 72. Bottom-up and Top-down Approaches for This Report
    Figure 73. Data Triangulation
    Figure 74. Key Executives Interviewed